Office for Protection from Research Risks

Office for Protection from Research Risks
Name	Office for Protection from Research Risks
Formed	20th century
Jurisdiction	United States Department of Health and Human Services
Headquarters	Bethesda, Maryland
Chief1 name	Not applicable
Parent agency	National Institutes of Health
Website	None

Contents

Office for Protection from Research Risks is a defunct or historical advisory office associated with oversight of biomedical and behavioral research involving human subjects and animals. It operated in the context of regulatory frameworks such as the National Research Act, the Common Rule, and interactions with agencies like the National Institutes of Health, the Food and Drug Administration, and the Centers for Disease Control and Prevention. The office engaged with bioethics debates stemming from cases like Tuskegee syphilis study, and policy developments influenced by reports from the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research and commissions convened after incidents such as the Willowbrook State School controversy.

History

The office emerged amid postwar debates involving institutions such as the National Academy of Sciences, the World Health Organization, and the Institute of Medicine following scandals exemplified by Tuskegee syphilis study and revelations associated with experiments referenced in the Nuremberg Code. In the 1970s and 1980s its role intersected with rulemaking processes that produced the Common Rule and influenced statutes including the Health Insurance Portability and Accountability Act of 1996 and amendments related to the Federal Policy for the Protection of Human Subjects. Key moments involved consultative exchanges with actors such as United States Congress, the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, and advisory bodies at the National Institutes of Health and the Department of Health and Human Services. The office's historical footprint is linked to institutional responses to ethical controversies at places like Johns Hopkins Hospital, Harvard Medical School, and Walter Reed Army Medical Center.

Its stated mission focused on protecting participants in research overseen by entities such as the National Institutes of Health, coordinating with the Food and Drug Administration, and advising bodies including the National Bioethics Advisory Commission and the President's Council on Bioethics. Responsibilities encompassed interpretation of regulations tied to the Common Rule, oversight of Institutional Review Boards at universities like Stanford University, Massachusetts Institute of Technology, and University of California, Berkeley, and engagement with animal care standards referenced by the Animal Welfare Act and the Public Health Service Policy on Humane Care and Use of Laboratory Animals. The office provided guidance relevant to clinical trials conducted at centers such as Mayo Clinic and Cleveland Clinic, liaised with funding programs at the National Cancer Institute and the National Institute of Allergy and Infectious Diseases, and responded to policy questions raised by outbreaks investigated by the Centers for Disease Control and Prevention.

The office issued interpretations and guidance that complemented policies such as the Common Rule, the Belmont Report, and the Nuremberg Code, and provided operational clarifications affecting Institutional Review Boards at institutions like University of Michigan and University of California, San Francisco. Its guidance bore on consent processes influenced by ethical analyses from the National Academies of Sciences, Engineering, and Medicine and legal frameworks shaped by cases adjudicated in federal courts, including precedents referencing Katz v. United States-era privacy principles. The office also advised on standards that intersected with the Health Insurance Portability and Accountability Act of 1996 and with research oversight practices adopted by entities like Centers for Medicare & Medicaid Services.

Programs often emphasized human subjects protections in clinical trials funded by the National Institutes of Health and compliance assistance for Institutional Review Boards at academic health centers such as University of Chicago, Duke University, and Johns Hopkins University. Activities included training initiatives paralleling curricula developed by the Office for Human Research Protections, collaborations with the Food and Drug Administration on investigational new drug protocols, and coordination with international bodies like the World Health Organization on research ethics during public health emergencies, echoing procedures later used in responses to outbreaks involving Ebola virus epidemic in West Africa and Zika virus epidemic. The office also contributed to animal welfare oversight aligning with National Research Council recommendations and funding conditions coming from the National Science Foundation.

Criticisms mirrored broader debates that engaged entities such as Congress and advocacy groups like American Civil Liberties Union and ethics scholars affiliated with Georgetown University and Princeton University. Critics argued the office sometimes produced guidance seen as too permissive by reformers referencing the Tuskegee syphilis study, while others contended it imposed burdens on researchers at institutions like MIT and Caltech. Disputes arose concerning transparency comparable to controversies involving Willowbrook State School investigations and debates over regulatory scope similar to conflicts about the Common Rule revisions. Legal challenges and congressional inquiries invoked actors including the Government Accountability Office and committees of United States Senate and United States House of Representatives.

Category:Research ethics